Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2018 09:30 ET | Source: PREDICTIVE TECHNOLOGY GROUP, INC.

Predictive Technology Group (PRED) Appoints John C. Nelson, M.D., M.P.H. to the Predictive Technology Group Scientific Advisory Board

SALT LAKE CITY, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED) announces that Dr. John C. Nelson, M.D., M.P.H. will join the Predictive Technology Group...
April 07, 2015 20:25 ET | Source: Mesoblast

Mesoblast Phase 3 Program For Degenerative Disc Disease To Include European Sites After Positive Meeting With European Medicines Agency

NEW YORK and MELBOURNE, Australia, April 7, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that following positive feedback from its recent meeting with the...
February 02, 2014 20:06 ET | Source: Mesoblast

Boardroom Radio Interview with Mesoblast Chief Executive

NEW YORK, Feb. 2, 2014 (GLOBE NEWSWIRE) -- Audio link - http://www.brrmedia.com/event/120127BRR Today at Boardroom Radio (BRR) we're once again joined by Mr Silviu Itescu, who is...
April 22, 2013 04:07 ET | Source: Mesoblast

MESOBLAST REPORTS POSITIVE INTERIM RESULTS IN PHASE 2 TRIAL OF PROPRIETARY ADULT STEM CELLS FOR INTERVERTEBRAL DISC REPAIR

Mesoblast's Phase 2 trial of allogeneic, or "off-the-shelf", Mesenchymal Precursor Cells (MPCs) injected into damaged intervertebral discs has now completed six-month follow-up for all 100...